This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
In patients with axial spondyloarthritis and a history of cardiovascular events, recurrent cardiovascular events were frequent, but exposure to a TNF inhibitor reduced the risk for these events.
Medscape Medical News